ID

15117

Beschreibung

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01508949

Link

https://clinicaltrials.gov/show/NCT01508949

Stichworte

  1. 16.05.16 16.05.16 -
Hochgeladen am

16. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT01508949

Eligibility Diabetes NCT01508949

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Beschreibung

diabetes mellitus type 2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
Beschreibung

diet therapy; sulphonylurea or repaglinide

Datentyp

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0038766
UMLS CUI [3]
C0246689
hba1c for diet treated subjects 6.5-12%, both inclusive
Beschreibung

hba1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
Beschreibung

hba1c for sulphonylurea or repaglinide treated subjects

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038766
UMLS CUI [1,2]
C0019018
UMLS CUI [2,1]
C0246689
UMLS CUI [2,2]
C0019018
body mass index (bmi) at least 27 kg/m^2
Beschreibung

bmi

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
euthyroid subjects
Beschreibung

euthyroid

Datentyp

boolean

Alias
UMLS CUI [1]
C0117002
fasting blood glucose 7-14 mmol/l
Beschreibung

fasting blood glucose

Datentyp

boolean

Alias
UMLS CUI [1]
C0428568
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired liver function
Beschreibung

impaired liver function

Datentyp

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Beschreibung

impaired renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0151746
cardiac problems
Beschreibung

cardiac problems

Datentyp

boolean

Alias
UMLS CUI [1]
C0262402
uncontrolled treated/untreated hypertension
Beschreibung

hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C0020538
recurrent severe hypoglycaemia as judged by the investigator
Beschreibung

hypoglycaemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0020615
known or suspected allergy to trial product or related products
Beschreibung

allergy to trial product

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
Beschreibung

medication

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0202042
UMLS CUI [1,3]
C0005910

Ähnliche Modelle

Eligibility Diabetes NCT01508949

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
diet therapy; sulphonylurea or repaglinide
Item
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
boolean
C0012159 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0246689 (UMLS CUI [3])
hba1c
Item
hba1c for diet treated subjects 6.5-12%, both inclusive
boolean
C0019018 (UMLS CUI [1])
hba1c for sulphonylurea or repaglinide treated subjects
Item
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
boolean
C0038766 (UMLS CUI [1,1])
C0019018 (UMLS CUI [1,2])
C0246689 (UMLS CUI [2,1])
C0019018 (UMLS CUI [2,2])
bmi
Item
body mass index (bmi) at least 27 kg/m^2
boolean
C1305855 (UMLS CUI [1])
euthyroid
Item
euthyroid subjects
boolean
C0117002 (UMLS CUI [1])
fasting blood glucose
Item
fasting blood glucose 7-14 mmol/l
boolean
C0428568 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
impaired liver function
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
impaired renal function
Item
impaired renal function
boolean
C0151746 (UMLS CUI [1])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
uncontrolled treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0020615 (UMLS CUI [1])
allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1])
medication
Item
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
boolean
C0013227 (UMLS CUI [1,1])
C0202042 (UMLS CUI [1,2])
C0005910 (UMLS CUI [1,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video